Pluri Inc. Receivables from Customers
Pluri Inc. (PLUR) had Receivables from Customers of $87.00 thousand as of 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Balance Sheet › Assets
us-gaap:ReceivablesFromCustomers · last filed 2026-09-10
- 2026-06-30: Receivables from Customers $87.00K.
- 2026-03-31: Receivables from Customers $99.00K.
- 2025-12-31: Receivables from Customers $169.00K.
- 2025-09-30: Receivables from Customers $294.00K.
| Period end | Receivables from Customers |
|---|---|
| 2026-06-30 | $87.00K 10-K · filed 2026-09-10 |
| 2026-03-31 | $99.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $169.00K 10-Q · filed 2026-02-12 |
| 2025-09-30 | $294.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $236.00K 10-K · filed 2026-09-10 |
| 2025-03-31 | $178.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $140.00K 10-Q · filed 2025-02-11 |
| 2024-06-30 | $34.00K 10-K · filed 2025-09-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |